Skip to content

Prime Medicine PRME Total Operating Expenses

Total Operating Expenses at other companies

CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$131.71M-11.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$138.95M+9.6%
Sana Biotechnology logo
Sana BiotechnologySANA
$48.61M-4.0%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$5.23M+62.2%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$41.11M-5.5%

Segments

By segment

See full
Reportable Segment$51.51M-4.3%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's total operating expenses?
Prime Medicine (PRME) reported total operating expenses of $51.51M in Q1 2026.
How has Prime Medicine's total operating expenses changed year-over-year?
Prime Medicine's total operating expenses decreased by 4.3% year-over-year, from $53.85M to $51.51M.
What is the long-term trend for Prime Medicine's total operating expenses?
Over 3 years (2022 to 2025), Prime Medicine's total operating expenses has grown at a 22.3% compound annual growth rate (CAGR), from $116.54M to $212.98M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.